Semaglutide vs PEG-MGF

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Semaglutide

Semaglutide is a GLP-1 receptor agonist that has revolutionized weight management and diabetes treatment. FDA-approved as Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral form), it has become one of the most prescribed peptides worldwide.

Full details →

PEG-MGF

PEG-MGF (PEGylated Mechano Growth Factor) is a variant of IGF-1 that is produced in response to muscle damage. PEGylation extends its half-life from minutes to several hours, making it practical for use.

Full details →

Side-by-Side Comparison

AspectSemaglutidePEG-MGF
MechanismMimics glucagon-like peptide-1 (GLP-1) to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through hypothalamic signaling. The result is significant reduction in food intake and improved glycemic control.Activates muscle satellite cells (stem cells) and promotes their fusion to existing muscle fibers for repair and growth. MGF is produced naturally in response to mechanical stress on muscles.
Typical DosageWegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.Research protocols typically use 200-400mcg injected into targeted muscle groups 2-3 times weekly, usually post-workout.
AdministrationSubcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.Intramuscular injection, ideally into muscles trained that day. Best administered post-workout when satellite cell activation is relevant.
Side EffectsCommon: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.Injection site soreness, potential hypoglycemia, and localized swelling. Generally well-tolerated.
Best For

Key Differences

Unique to Semaglutide:

Unique to PEG-MGF:

Ready to Learn More?